Crossoak Pharma Limited in Berkhamsted, HP4 3HX

Description

Data updated on: 01-11-2023

Crossoak Pharma Limited has existed on the market for at least sixteen years. Started with registration number 06557544 in 2008, it is registered at 24 Shrublands Road, Berkhamsted HP4 3HX. The company's SIC code is 62090, that means Other information technology service activities. The business latest filed accounts documents cover the period up to 2023-04-30 and the most current annual confirmation statement was filed on 2023-04-07.

Derek W. is the firm's only director, who was selected to lead the company sixteen years ago. Moreover, the managing director's efforts are often helped with by a secretary - Marie W., who joined the business in April 2008.

Derek W. is the individual who has control over this firm, owns over 1/2 to 3/4 of company shares .

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-04-30	2012-04-30	2013-04-30	2014-04-30	2015-04-30	2016-04-30	2017-04-30	2018-04-30	2019-04-30	2020-04-30	2021-04-30	2022-04-30	2023-04-30
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	25 775	60 263	69 017	114 677	82 474	107 283	136 911	183 295

Balance Sheet
Current Assets	45 076	83 990	100 666	159 512	94 743	121 652	157 811	209 971	135 718	159 796	158 408	158 072	91 004
Net Assets Liabilities								183 295	150 827	133 541	117 763	113 167	61 376
Cash Bank In Hand	15 609	62 397	69 221	109 765	47 431	88 428	101 393	132 388
Debtors	29 467	21 593	31 445	49 747	47 312	33 224	56 418	77 583
Net Assets Liabilities Including Pension Asset Liability	25 775	60 263	69 017	114 677	82 474	107 283	136 911	183 295
Tangible Fixed Assets	2 667	2 352	1 764	1 322	2 147	8 157

Capital & Reserves
Called Up Share Capital	10	10	10	10	10	10
Profit Loss Account Reserve	25 765	60 253	69 007	114 667	82 464	107 273
Shareholder Funds	25 775	60 263	69 017	114 677	82 474	107 283	136 911	183 295

Other Financial Data
Accrued Liabilities Not Expressed Within Creditors Subtotal								720	106			53	37
Average Number Employees During Period								2	2	2	2	2	2
Creditors								39 179	12 765	29 947	44 828	47 732	34 882
Fixed Assets	2 667	2 352	1 764	1 322	2 147	8 157	6 862	4 895	3 670	2 752	3 563	2 674	3 013
Net Current Assets Liabilities	23 641	58 381	67 605	113 620	80 703	100 758	130 069	179 120	147 263	130 789	114 200	110 546	58 400
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal						26 859	7 480	8 328	24 310	940	620	206	2 278
Total Assets Less Current Liabilities	26 308	60 733	69 369	114 942	82 850	108 915	136 931	184 015	150 933	133 541	117 763	113 220	61 413
Advances Credits Directors							31 778	47 210	455	8 293
Advances Credits Made In Period Directors								16 000	455
Advances Credits Repaid In Period Directors								568	47 210
Creditors Due Within One Year Total Current Liabilities	21 435	24 916
Provisions For Liabilities Charges	533	470	352	265	376	1 632
Tangible Fixed Assets Additions		469			1 449	8 728
Tangible Fixed Assets Cost Or Valuation	3 556	4 025	4 025	4 025	5 474	14 202
Tangible Fixed Assets Depreciation	889	1 673	2 261	2 703	3 327	6 045
Tangible Fixed Assets Depreciation Charge For Period		784
Accruals Deferred Income							20	720
Creditors Due Within One Year		25 609	33 061	45 892	14 040	20 894	35 222	39 179
Number Shares Allotted				10
Par Value Share				1
Share Capital Allotted Called Up Paid			10	10
Tangible Fixed Assets Depreciation Charged In Period			588	442	624	2 718

Company staff

Marie W.

Role: Secretary

Appointed: 15 April 2008

Latest update: 30 April 2024

Derek W.

Role: Director

Appointed: 15 April 2008

Latest update: 30 April 2024

People with significant control

Derek W.

Notified on 6 April 2016

Nature of control:

over 1/2 to 3/4 of shares

Accounts Documents

Account next due date	31 January 2025
Account last made up date	30 April 2023
Confirmation statement next due date	21 April 2024
Confirmation statement last made up date	07 April 2023

Annual Accounts 8 July 2013
Start Date For Period Covered By Report	2012-05-01
End Date For Period Covered By Report	2013-04-30
Date Approval Accounts	8 July 2013
Annual Accounts 11 June 2014
Start Date For Period Covered By Report	2013-05-01
End Date For Period Covered By Report	2014-04-30
Date Approval Accounts	11 June 2014
Annual Accounts 12 June 2015
Start Date For Period Covered By Report	2014-05-01
End Date For Period Covered By Report	2015-04-30
Date Approval Accounts	12 June 2015
Annual Accounts 6 June 2016
Start Date For Period Covered By Report	2015-05-01
End Date For Period Covered By Report	2016-04-30
Date Approval Accounts	6 June 2016
Annual Accounts 11 August 2017
Start Date For Period Covered By Report	2016-05-01
End Date For Period Covered By Report	2017-04-30
Date Approval Accounts	11 August 2017
Annual Accounts 24 May 2018
Start Date For Period Covered By Report	2017-05-01
End Date For Period Covered By Report	2018-04-30
Date Approval Accounts	24 May 2018
Annual Accounts
Start Date For Period Covered By Report	2018-05-01
End Date For Period Covered By Report	30/04/2019
Annual Accounts
Start Date For Period Covered By Report	2019-05-01
End Date For Period Covered By Report	30/04/2020
Annual Accounts
Start Date For Period Covered By Report	2020-05-01
End Date For Period Covered By Report	30/04/2021
Annual Accounts
Start Date For Period Covered By Report	2021-05-01
End Date For Period Covered By Report	30/04/2022
Annual Accounts
Start Date For Period Covered By Report	2022-05-01
End Date For Period Covered By Report	30/04/2023

Crossoak Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Marie W.

Derek W.

Form 10 Directors Fd Ltd

People with significant control

Derek W.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies